• HO-1-Mediated ROS Modulation Disrupts HBV Replication: New I

  2026-05-07

  This study demonstrates that isochlorogenic acid A (ICAA) impairs multiple stages of the hepatitis B virus (HBV) life cycle by upregulating heme oxygenase-1 (HO-1) and modulating intracellular reactive oxygen species (ROS). The findings clarify the antiviral mechanism of ICAA and highlight the importance of HO-1 signaling in HBV morphogenesis and persistence.

• Verbascoside: Precision PKC/NF-κB Inhibition in Bone Researc

  2026-05-06

  This thought-leadership article explores the mechanistic depth and strategic value of Verbascoside, a selective PKC/NF-κB inhibitor, for translational researchers investigating osteoclastogenesis and bone pathology. Integrating recent mechanistic insights, quantitative benchmarks, and protocol guidance, the discussion frames Verbascoside not merely as a molecular tool but as a catalyst for next-generation research in bone metabolism and inflammatory signaling modulation.

• Distinct Roles of GluN2A/2B in TMJ Inflammation-Induced Allo

  2026-05-06

  This study reveals that GluN2A and GluN2B NMDAR subunits distinctly regulate connexins and pannexin expression in trigeminal ganglia during temporomandibular joint (TMJ) inflammation, driving orofacial inflammatory allodynia. By dissecting intracellular signaling pathways in vivo and in vitro, the work identifies precise molecular targets for future pain therapeutics and guides research on peripheral sensitization in TMJ disorders.

• Benzyl-Activated Streptavidin Magnetic Beads: Precision in E

  2026-05-05

  Discover how Benzyl-activated Streptavidin Magnetic Beads enable precise, low-background capture of biotinylated molecules for advanced early cell death detection and quantitative assays. This article explores under-addressed applications and protocol optimization strategies for K1301, building upon recent breakthroughs in apoptosis research.

• Pexidartinib (PLX3397): Advancing Microglial Modulation in C

  2026-05-05

  Explore the unique dual role of Pexidartinib (PLX3397) in CSF1R-mediated signaling inhibition and microglial modulation. This in-depth review reveals fresh insights for cancer research and neuroimmune studies, grounded in recent scientific breakthroughs.

• Antipyrine in High-Throughput BBB and CNS Research Workflows

  2026-05-04

  Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) sets a benchmark for reproducibility and solubility in advanced blood-brain barrier (BBB) and pharmacokinetic models. This article details evidence-driven workflows, troubleshooting strategies, and the transformative impact of the latest surrogate BBB model for CNS drug discovery.

• Beclin1 Knockdown Reduces Ferroptosis in Doxorubicin Liver I

  2026-05-04

  This study demonstrates that Beclin1 deficiency alleviates doxorubicin-induced liver injury by inhibiting both ferroptosis and autophagy in hepatocytes. These findings clarify the mechanistic role of Beclin1 and DHODH in the progression of oxidative liver damage, with implications for targeting ferroptosis in mitigating chemotherapy-associated hepatotoxicity.

• AMPK’s Dual Role in Autophagy During Cellular Energy Stress

  2026-05-03

  This study overturns the prevailing model by demonstrating that AMPK suppresses, rather than induces, autophagy through direct inhibition of ULK1, while simultaneously preserving autophagy machinery for later recovery. These findings reshape experimental approaches to metabolic signaling and cellular energy stress adaptation.

• Deferasirox Fe3+ Chelate: Optimizing Iron Chelation Research

  2026-05-02

  Deferasirox Fe3+ chelate from APExBIO delivers high-purity, DMSO-soluble performance for translational iron overload studies. This article demystifies its protocol integration, troubleshooting, and experimental advantages for beta-thalassemia, chronic anemia, and mechanistic iron chelation research.

• TAK-715: Advanced p38 MAPK Inhibitor for Cytokine Research

  2026-05-02

  TAK-715 stands out as a dual-action, highly selective p38 MAPK inhibitor that not only blocks kinase activity but also promotes dephosphorylation, offering a unique edge in inflammation and cytokine signaling research. Its robust performance in cell-based and in vivo models, coupled with actionable workflow guidance, makes it an indispensable tool for dissecting complex chronic inflammatory pathways.

• GSK3 Inhibition as a Host-Directed Strategy Against Tubercul

  2026-05-01

  The referenced iScience study demonstrates that glycogen synthase kinase 3 (GSK3) inhibition in human macrophages restricts intracellular growth of Mycobacterium tuberculosis. This host-directed approach reveals new therapeutic avenues beyond traditional antibiotics and highlights the potential for kinase inhibitors to complement multi-drug resistant tuberculosis strategies.

• QRICH1 Amplifies HBV-Induced HMGB1 Secretion via ER Stress i

  2026-04-30

  This study identifies QRICH1 as a key mediator that enhances HBV-induced HMGB1 translocation and secretion in hepatocytes through endoplasmic reticulum (ER) stress. These findings clarify a novel molecular pathway contributing to hepatic fibrosis progression, offering new targets for liver disease intervention strategies.

• Early Life Adversity Impairs Innate Defense via Oxytocin Def

  2026-04-30

  This study uncovers how early life adversity (ELA), modeled as postnatal social deprivation in mice, impairs visually evoked innate defensive behaviors through disrupted oxytocin signaling in the superior colliculus. The findings advance understanding of the neurobiological pathways linking ELA to altered fear processing and potential psychopathological risk.

• Berberrubine Modulates Chemokine Expression in Retinal Cells

  2026-04-29

  This study rigorously demonstrates that berberrubine suppresses IL-8 and MCP-1 expression in human retinal pigment epithelial (ARPE-19) cells by inhibiting NF-κB nuclear translocation following inflammatory cytokine stimulation. These findings highlight a mechanistic basis for berberrubine as an anti-inflammatory research agent in ocular models, with methodological clarity supporting translational relevance.

• Perifosine (KRX-0401): Mechanistic Insights for Precision Ap

  2026-04-29

  Explore how Perifosine (KRX-0401) enables highly specific apoptosis and Akt/mTOR pathway inhibition, with in-depth analysis of its mechanistic actions and new evidence for optimizing research assays. This article offers a unique perspective on Perifosine’s role in cell death modulation and radiosensitization.

451 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page